| Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells C Mani, S Jonnalagadda, J Lingareddy, S Awasthi, WH Gmeiner, K Palle Breast Cancer Research 21, 1-14, 2019 | 61 | 2019 |
| Novel N, N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors S Jonnalagadda, SK Jonnalagadda, CT Ronayne, GL Nelson, LN Solano, ... Oncotarget 10 (24), 2355, 2019 | 37 | 2019 |
| Development of novel silyl cyanocinnamic acid derivatives as metabolic plasticity inhibitors for cancer treatment GL Nelson, CT Ronayne, LN Solano, SK Jonnalagadda, S Jonnalagadda, ... Scientific reports 9 (1), 18266, 2019 | 20 | 2019 |
| Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents LN Solano, GL Nelson, CT Ronayne, S Jonnalagadda, SK Jonnalagadda, ... Scientific reports 10 (1), 17969, 2020 | 18 | 2020 |
| A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma A Khammanivong, J Saha, AK Spartz, BS Sorenson, AG Bush, ... Veterinary and Comparative Oncology 18 (3), 324-341, 2020 | 13 | 2020 |
| Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents GL Nelson, CT Ronayne, LN Solano, SK Jonnalagadda, S Jonnalagadda, ... Bioorganic & Medicinal Chemistry Letters 52, 128411, 2021 | 11 | 2021 |
| Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents SK Jonnalagadda, K Wielenberg, CT Ronayne, S Jonnalagadda, P Kiprof, ... Bioorganic & Medicinal Chemistry Letters 30 (14), 127259, 2020 | 11 | 2020 |
| Development and radiosynthesis of the first 18F‐labeled inhibitor of monocarboxylate transporters (MCTs) M Sadeghzadeh, RP Moldovan, S Fischer, B Wenzel, FA Ludwig, ... Journal of Labelled Compounds and Radiopharmaceuticals 62 (8), 411-424, 2019 | 10 | 2019 |
| Access to highly strained tricyclic ketals derived from coumarins SK Jonnalagadda, BI Huwaimel, S Jonnalagadda, JC Garrison, ... The Journal of organic chemistry 87 (6), 4476-4482, 2022 | 8 | 2022 |
| Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold BI Huwaimel, SK Jonnalagadda, S Jonnalagadda, S Kumari, A Nocentini, ... Drug development research 84 (4), 681-702, 2023 | 7 | 2023 |
| Case report: intra-tumoral vaccinations of quadrivalent HPV-L1 peptide vaccine with topical TLR-7 agonist following recurrence: complete resolution of HPV-HR-associated … M Reedy, S Jonnalagadda, K Palle Pathology and Oncology Research 27, 1609922, 2021 | 7 | 2021 |
| Synthesis and Evaluation of Baylis‐Hillman Reaction Derived Imidazole and Triazole Cinnamates as Antifungal Agents GL Nelson, MJ Williams, S Jonnalagadda, MA Alam, G Mereddy, ... International journal of medicinal chemistry 2018 (1), 5758076, 2018 | 6 | 2018 |
| Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging M Sadeghzadeh, B Wenzel, D Gündel, W Deuther-Conrad, M Toussaint, ... Molecules 25 (10), 2309, 2020 | 5 | 2020 |
| Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader AV Carmona, S Jonnalagadda, AM Case, K Maddeboina, ... Communications Chemistry 7 (1), 95, 2024 | 3 | 2024 |
| Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: A Pharmacokinetics Study in Healthy and Stroke Animals Y Zhang, S Sharma, S Jonnalagadda, S Kumari, A Queen, SH Esfahani, ... Pharmaceutical Research 40 (11), 2747-2758, 2023 | 3 | 2023 |
| Development of the first F-18-labeled MCT1/MCT4 lactate transport inhibitor: Radiosynthesis and preliminary in vivo evaluation in mice M Sadeghzadeh, R Moldovan, B Wenzel, M Kranz, W Deuther-Conrad, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 62, S59-S60, 2019 | 3 | 2019 |
| Chlorinated benzothiadiazines inhibit angiogenesis through suppression of VEGFR2 phosphorylation BI Huwaimel, S Jonnalagadda, S Jonnalagadda, FT Zahra, A Nocentini, ... Bioorganic & medicinal chemistry 67, 116805, 2022 | 2 | 2022 |
| Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53 CT Ronayne, SK Jonnalagadda, S Jonnalagadda, GL Nelson, LN Solano, ... Biochemical and Biophysical Research Communications 562, 127-132, 2021 | 2 | 2021 |
| RAD6-mediated epigenetic reprogramming contributes to therapy-induced chemo-resistance in ovarian cancer TR Omy, S Jonnalagadda, M Reedy, K Palle Cancer Research 81 (13_Supplement), 2111-2111, 2021 | 2 | 2021 |
| Expedient Single Step Access to Strained Tricyclic Ketals S Jonnalagadda, B Huwaimel, S Jonnalagadda, J Garrison, PC Trippier | 1 | 2021 |
